Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy
- PMID: 8306589
- DOI: 10.1111/j.1464-5491.1993.tb00009.x
Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy
Abstract
This study evaluated the reproducibility of nerve function assessment in a group of 132 diabetic patients with moderate peripheral polyneuropathy. Patients were investigated at the beginning and the end of the run-in period (a 1-month placebo period) of a multicentre trial of an aldose-reductase inhibitor (Ponalrestat). Reproducibility was evaluated by performing four types of tests: quantitative visual scales of symptoms, quantitative sensory assessment (vibration perception thresholds in medial malleolus and great toe, foot thermal perception threshold to hot and cold), electrophysiological investigations on the dominant side (conduction velocities and potential amplitudes of sensory and median motor nerve, sural and peroneal nerves, amplitudes of F waves of median motor and peroneal nerves) and cardiac autonomic tests (Valsalva, deep-breathing, lying-to-standing). Reproducibility was poor for symptoms, thermal sensitivity, and potential amplitudes. It was satisfactory (total coefficient of variation < 50%) for all the other parameters and even very good (total variation coefficient < 26%, intra-subject variation factors corresponding to < 56% of total variance) for velocities of sensory and median motor and peroneal nerves, the amplitudes of F waves and the three autonomic tests. For most of the parameters total variance was mainly related to inter-subject variability. However, inter-subject variability for the three cardiac autonomic tests was very low and at least one cardiac autonomic test was altered in all the patients. Inter-centre variability was low for all the parameters, except for action potential amplitudes and for F wave velocity of the median motor nerve. This study suggests those parameters that are appropriate for the assessment of diabetic neuropathy and for therapeutic trials.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat Trial.J Diabetes Complications. 1992 Apr-Jun;6(2):123-30. doi: 10.1016/1056-8727(92)90023-e. J Diabetes Complications. 1992. PMID: 1611136 Clinical Trial.
-
One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy.Diabetes Res Clin Pract. 1991 Oct;14(1):63-73. doi: 10.1016/0168-8227(91)90054-h. Diabetes Res Clin Pract. 1991. PMID: 1748064 Clinical Trial.
-
A 12-month randomized controlled study of the aldose reductase inhibitor ponalrestat in patients with chronic symptomatic diabetic neuropathy.Diabet Med. 1992 Jun;9(5):463-8. doi: 10.1111/j.1464-5491.1992.tb01818.x. Diabet Med. 1992. PMID: 1611835 Clinical Trial.
-
Effects of aldose reductase inhibitors on the progression of nerve fiber damage in diabetic neuropathy.J Diabetes Complications. 1992 Jan-Mar;6(1):35-8. doi: 10.1016/1056-8727(92)90046-n. J Diabetes Complications. 1992. PMID: 1562756 Review.
-
WITHDRAWN: Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy.Cochrane Database Syst Rev. 1996 Apr 22;(1):CD002182. doi: 10.1002/14651858.CD002182. Cochrane Database Syst Rev. 1996. PMID: 17636697
Cited by
-
Neuropathic pain: is quantitative sensory testing helpful?Curr Diab Rep. 2012 Aug;12(4):393-402. doi: 10.1007/s11892-012-0282-7. Curr Diab Rep. 2012. PMID: 22623149 Review.
-
APOE gene polymorphisms and diabetic peripheral neuropathy.Arch Med Sci. 2012 Sep 8;8(4):583-8. doi: 10.5114/aoms.2012.30279. Arch Med Sci. 2012. PMID: 23056065 Free PMC article.
-
Measurement of somatic neuropathy for clinical practice and clinical trials.Curr Diab Rep. 2001 Dec;1(3):208-15. doi: 10.1007/s11892-001-0036-4. Curr Diab Rep. 2001. PMID: 12643201 Review.
-
A trial of proficiency of nerve conduction: greater standardization still needed.Muscle Nerve. 2013 Sep;48(3):369-74. doi: 10.1002/mus.23765. Epub 2013 Jul 17. Muscle Nerve. 2013. PMID: 23861198 Free PMC article.
-
Multicenter assessment of quantitative sensory testing (QST) for the detection of neuropathic-like pain responses using the topical capsaicin model.Can J Pain. 2018 Oct 23;2(1):266-279. doi: 10.1080/24740527.2018.1525682. eCollection 2018. Can J Pain. 2018. PMID: 35005384 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical